HF
VIR icon

HRT Financial’s Vir Biotechnology VIR Stock Holding History

HRT Financial’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.14M Buy
+308,104
New +$2.93M 0.01% 1435
2026
Q1 		– Sell
-591,648
Closed -$3.57M – 4798
2025
Q4 		$3.57M Buy
591,648
+414,864
+235% +$2.47M 0.01% 955
2025
Q3 		$1.01M Sell
176,784
-5,745
-3% -$29.4K ﹤0.01% 1516
2025
Q2 		$919K Buy
182,529
+166,946
+1,071% +$895K ﹤0.01% 1305
2025
Q1 		$100K Sell
15,583
-68,466
-81% -$609K ﹤0.01% 2148
2024
Q4 		$616K Buy
84,049
+35,027
+71% +$276K ﹤0.01% 1341
2024
Q3 		$367K Buy
49,022
+13,716
+39% +$119K ﹤0.01% 1724
2024
Q2 		$314K Buy
+35,306
New +$339K ﹤0.01% 1491
2024
Q1 		– Sell
-61,095
Closed -$614K – 3156
2023
Q4 		$614K Buy
+61,095
New +$558K ﹤0.01% 1258
2023
Q2 		– Sell
-118,011
Closed -$2.75M – 3341
2023
Q1 		$2.75M Buy
+118,011
New +$3.02M 0.03% 458
2022
Q2 		– Sell
-25,254
Closed -$649K – 3788
2022
Q1 		$649K Buy
+25,254
New +$749K ﹤0.01% 1441
2021
Q3 		– Sell
-20,558
Closed -$971K – 3794
2021
Q2 		$971K Sell
20,558
-33,080
-62% -$1.5M 0.01% 1157
2021
Q1 		$2.75M Buy
+53,638
New +$2.89M 0.03% 467

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

HRT Financial's VIR Position: Q2 2026 in Review

HRT Financial opened a new position in Vir Biotechnology (VIR) in Q2 2026: 308,104 shares worth $3.14M. The stake represents 0.01% of the portfolio and ranks #1435 among its holdings. This is a return to the name: HRT Financial previously reported a position in VIR as recently as Q4 2025.

HRT Financial first reported a position in VIR in Q1 2021 and has held it in 13 quarters since. The position peaked at $3.57M in Q4 2025. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • HRT Financial held 308,104 shares of Vir Biotechnology worth $3.14M as of Q2 2026.
  • Vir Biotechnology was a new HRT Financial position in Q2 2026.
  • Vir Biotechnology made up 0.01% of HRT Financial's portfolio in Q2 2026, its #1435 holding.
  • HRT Financial first reported a position in Vir Biotechnology in Q1 2021 and has held it in 13 quarters since.
  • HRT Financial's Vir Biotechnology position peaked at $3.57M in Q4 2025.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.